Ralph DeFronzo, Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio. ... biotech and finance leaders seeking clear, ...
News
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
- CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives. SAN ANTONIO, TX / ACCESS ...
- Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating ... - WVNews
... San Antonio Breast Cancer Symposium (SABCS) providing compelling mechanistic and early clinical evidence supporting the activity of paxalisib, the ...
- Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy
... San Antonio Breast Cancer Symposium. Patients who received the Pfizer ... Fierce Biotech · Fierce Healthcare · Fierce Pharma. Our Events. Life ...
- Novel endocrine therapy reduces the risk of breast cancer recurrence - Medical Xpress
The results were shared at the San Antonio Breast Cancer Symposium (SABCS) by global principal investigator, Dr. Aditya Bardia, professor of ...